Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
The advent of cancer immunotherapy has imparted a transformative impact on cancer treatment paradigms by harnessing the power of the immune system. However, the challenge of practical and precise targeting of malignant cells persists. To address this, engineered nanoparticles (NPs) have emerged as a...
Saved in:
Main Authors: | Xueqiang Peng (Author), Jianjun Fang (Author), Chuyuan Lou (Author), Liang Yang (Author), Shaobo Shan (Author), Zixian Wang (Author), Yutong Chen (Author), Hangyu Li (Author), Xuexin Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
by: Yu Gao, et al.
Published: (2024) -
Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
by: Wanting Hou, et al.
Published: (2022) -
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy
by: Ziyang (Steve), et al.
Published: (2024) -
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
by: Yukai Shan, et al.
Published: (2024) -
Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells
by: Chenggong Liu, et al.
Published: (2020)